Antiplatelet Therapy in Cardiovascular Disease (Q168211)

From geokb
Revision as of 14:17, 24 May 2024 by Sky (talk | contribs) (‎Created a new Item: Added new OpenAlex topic claimed by USGS staff from API)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
This cluster of papers focuses on the use of antiplatelet therapy, including aspirin, clopidogrel, and ticagrelor, in the prevention of cardiovascular events, especially in the context of percutaneous coronary intervention
  • Aspirin
  • Clopidogrel
  • Ticagrelor
  • Platelet Reactivity
  • Cardiovascular Events
  • Percutaneous Coronary Intervention
  • Genetic Polymorphisms
  • Bleeding Risk
  • Thrombotic Events
  • CYP2C19 Genotype
Language Label Description Also known as
English
Antiplatelet Therapy in Cardiovascular Disease
This cluster of papers focuses on the use of antiplatelet therapy, including aspirin, clopidogrel, and ticagrelor, in the prevention of cardiovascular events, especially in the context of percutaneous coronary intervention
  • Aspirin
  • Clopidogrel
  • Ticagrelor
  • Platelet Reactivity
  • Cardiovascular Events
  • Percutaneous Coronary Intervention
  • Genetic Polymorphisms
  • Bleeding Risk
  • Thrombotic Events
  • CYP2C19 Genotype

Statements